Searchable abstracts of presentations at key conferences in endocrinology

ea0004oc24 | Steroid hormone action | SFE2002

A LONGER TERM TRIAL OF DHEA REPLACEMENT IN ADDISON'S DISEASE

Gurnell E , Hunt P , Curran S , Conway C , Huppert F , Herbert J , Chatterjee V

In a double-blind study, 106 patients (44 males, 62 females, age 20-64 years) with Addison's disease, were randomised to receive either 50mg of micronised DHEA or placebo orally daily for 12 months. Psychological and biochemical parameters were measured at baseline, 3 to 6 month intervals and post-washout; bone mineral density (BMD) and body composition were assessed by DEXA at baseline and 12 months.DHEAS levels rose significantly and were maintained th...

ea0002p37 | Endocrine tumours and neoplasia | SFE2001

Minimally invasive parathyroid surgery with intra-operative PTH measurement: an economical approach to the management of primary hyperparathyroidism

Gurnell E , Poultsidis A , McFarlane I , Sarkar A , Curran S , Hitchcock M , Munday I , Raggatt P , Balan K , Edwards O , Wishart G , Chatterjee V

BACKGROUND: Primary hyperparathyroidism (HPT) is increasingly diagnosed, particularly in an older population. Recent studies indicate improvement in bone mineral density (BMD) and psychological wellbeing even following treatment of apparent asymptomatic disease, supporting a lower threshold for surgical intervention. With disease being due to a solitary adenoma in most (83%) cases, we have utilised preoperative imaging together with intra-operative parathyroid hormone (IOPTH) ...